Skip to main content

April 2017

 

 

academics

 

Clinical research courses

Walk in interview in QA, QC at AISHWARYA HEALTHCARE

Aishwarya Group is a cGMP and WHO and other regulatory authorities certified company in pharmaceutical sector. Manufacturer of Liquid IV. WFI. Injectable.Ear Drop, Eye Drop. We are looking for motivated, energetic and experienced candidates for our Raddi location

Post : Officer. Sr. Officer, Executive.

Applications invited in BITS Pilani for post of Junior Research Fellow - M.Pharm, MS Pharm

The Birla Institute of Technology and Science, Pilani (BITS Pilani) is an all-India Institute for higher education. Founded in 1964 in collaboration with Massachusetts Institute of Technology (MIT), USA, it is one of the top most educational Institute in India.  The Department of Pharmacy at BITS Pilani is one of the few early schools of Pharmacy in India. Established in 1950, it blossomed into one of the most sought after Schools of Pharmacy. Currently the department offers Bachelor, Masters and Ph.D programs in Pharmacy. Faculties of Department of Pharmacy are actively involved in carrying out extra-mural research projects funded by various industries (Torrent, IPCA, Lubrizol, TTK LIG Ltd, SPIC, BASF, Etica Clinpharma, Pvt, Ltd) and Government bodies (SERB, ICMR, UGC, DBT, DST, CSIR).

Post : Junior Research Fellow - 01

Career for M.Pharm as Associate Scientist at Novartis

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Associate Scientist

Work as Senior Pharmacovigilance Specialist at Clinipace

Clinipace Worldwide is a different kind of CRO, where people are the backbone of our technology-amplified processes.  We are a global full-service digital Clinical Research Organization (dCRO) and one of the fastest growing companies in America.  Clinipace currently has a global footprint of 31 offices in 25 countries.  Our proprietary technology combined with an innovative service model transforms drug and medical device development.  We are proud to have a culture that is vibrant, supportive, performance-driven, and passionate while focusing on continual learning and development.  Our associates are passionate about their lives and bring that same passion to their work at Clinipace Worldwide.

Post : Pharmacovigilance Specialist Senior

Career in Johnson & Johnson for post of District Manager - Metabolics

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Post: District Manager - Metabolics

Merck Limited looking for Business Development Manager

Merck Limited was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.  Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd.

Post : Business Development Manager

Clinical Operations in Oncology Trials East Coast 2017

Clinical Operations in Oncology Trials (CTO) is the only operationally-focused oncology conference in the USA. Alongside our West Coast conference, the East Coast conference in the Boston biotech hub is tailored specifically for Clinical Operations/Development/Research and Medical Affairs pharma and biotech representatives in the region.  With a dynamic programme written for the industry, by the industry, our 7th annual CTO East Coast event and promises to be an engaging and memorable conference. Optimizing clinical processes within oncology trials to ensure effective patient recruitment, trial management and achieve trial success is central to this year’s conference.

Alzheon, Inc. announced publication of a newly elucidated molecular mechanism of action for tramiprosate, the active agent in the company’s lead clinical drug candidate, ALZ-801. The company’s Phase 3-ready candidate ALZ-801 is an optimized prodrug of tramiprosate, with a substantially improved pharmacokinetic and safety profile compared to tramiprosate.

Achillion Pharmaceuticals, Inc.announced the presentation of updated results from the ongoing phase 2 ‘604 Study’ being conducted by Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies (Janssen). These results were presented as an oral presentation during the European Association for the Study of the Liver (EASL) 2017 International Liver Congress in Amsterdam. These results demonstrate that the triple combination of simeprevir, odalasvir and AL-335 has the ability to shorten treatment duration, offer high efficacy and be generally well tolerated in those whose disease is caused by hepatitis C virus (HCV) genotype 1 (GT1), one of the most prevalent causes of hepatitis C globally.

(adsbygoogle = window.adsbygoogle || []).push({});